BioCentury
ARTICLE | Clinical News

Algisyl-LVR regulatory update

October 6, 2014 7:00 AM UTC

LoneStar Heart said it received CE Mark approval for its Algisyl-LVR hydrogel implant to treat advanced heart failure in patients with an enlarged left ventricle. The biologically inert polymer is inj...